Subscriber Login

Elsevier Business Intelligence brings you the most intuitive, flexible tool for drug pipeline research, tracking and analysis

Inteleos offers timely data to track biologics and drug development from preclinical through approval and post-marketing studies.

Inteleos at a glance:

Extensive coverage – Monitor trends in development of drugs and biologics, with in-depth regulatory submission and approval details.

Research advancement – Search and view the most recent trends and breakthroughs in science.

Business intelligence – Find info about new partners and competitors. Study outcomes to enhance your business.

Efficiencies – Save time by receiving personalized alerts on content updates relevant to your portfolio.

Currency – Stay up-to-date on competitors' activities, industry news and conference proceedings.

PLUS...

Competitor Profiles

  • Compare products with the same MoA or Drug Class in an interactive grid

Development Timelines

  • Compare stated expectations with actual development dates
  • Anticipated time to filing and launch

News and Review

  • Industry, conference and regulatory news from:
    • "The Pink Sheet"
    • Elsevier Global Medical News
  • Company releases


Flexible drug & clinical trial search with Boolean operator and filters options

  • New molecular entity
  • Fixed-dose combination
  • Orphan designation
  • Special age population

Interactive analysis tools

  • Fully exportable as graphics or as reports


Unsurpassed customer service - Discuss content queries directly with Inteleos staff!


It's quick and easy to get more information or to arrange a FREE web demonstration...

I would like to receive information regarding:
Inteleos

Please tell us:

:

or
Print and fax this form to: +1 (203) 838-3214
or contact
James DeFalco
1 (203) 838 4401 x104
j.defalco@elsevier.com

Copyright © 2009, Elsevier Business Intelligence